Literature DB >> 8862736

Concentration of rare earth elements, As, and Th in human brain and brain tumors, determined by neutron activation analysis.

G Zhuang1, Y Zhou, H Lu, W Lu, M Zhou, Y Wang, M Tan.   

Abstract

Toxic elements As and Th, six rare-earth elemental profiles of brain tumor tissues from 16 patients of astrocytomas (grade I-III), and normal human brain tissues of 18 male, age-matched autopsies serving as controls have been studied by radiochemical neutron activation analysis. P-204 [di(2-ethylhexyl) phosphate] extraction chromatography column was used for group separation of rare-earth element (REE) by one step. Compared with the normal brain tissues, the analytical results showed that the concentrations of Th, La, Ce, Gd, and Lu were significantly higher in tumor tissues (P < 0.01 or 0.001). The possible effects of REE on tumor cell were discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862736     DOI: 10.1007/BF02784543

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  2 in total

1.  Applications of neutron activation analysis to the study of age-related neurological diseases.

Authors:  W D Ehmann; W R Markesbery; E J Kasarskis; D E Vance; S S Khare; J D Hord; C M Thompson
Journal:  Biol Trace Elem Res       Date:  1987-08       Impact factor: 3.738

2.  Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium.

Authors:  A Höck; U Demmel; H Schicha; K Kasperek; L E Feinendegen
Journal:  Brain       Date:  1975-03       Impact factor: 13.501

  2 in total
  6 in total

1.  Assessing the chemical behavior and spatial distribution of yttrium and rare earth elements (YREEs) in a coastal aquifer adjacent to the Urmia Hypersaline Lake, NW Iran.

Authors:  Nassim Sohrabi; Nasrollah Kalantari; Vahab Amiri; Mohammad Nakhaei
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-15       Impact factor: 4.223

2.  In Vivo Uptake of Rare Earth Metals by Triple-Negative Breast Cancer Cells.

Authors:  Luca Roncati; Antonietta Morena Gatti; Giuseppe Barbolini; Francesco Piscioli; Teresa Pusiol; Antonio Maiorana
Journal:  Pathol Oncol Res       Date:  2017-02-09       Impact factor: 3.201

3.  A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood.

Authors:  Kenneth J Cohen; Iris C Gibbs; Paul G Fisher; Robert J Hayashi; Margaret E Macy; Lia Gore
Journal:  Neuro Oncol       Date:  2013-03-03       Impact factor: 12.300

Review 4.  Role of endolysosome function in iron metabolism and brain carcinogenesis.

Authors:  Peter W Halcrow; Miranda L Lynch; Jonathan D Geiger; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2021-06-15       Impact factor: 15.707

5.  Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.

Authors:  Claudia Paret; Alexandra Russo; Henrike Otto; Arnulf Mayer; Sebastian Zahnreich; Wolfgang Wagner; David Samuel; David Scharnhorst; David A Solomon; Girish Dhall; Kenneth Wong; Hannah Bender; Francesca Alt; Arthur Wingerter; Marie A Neu; Olaf Beck; Dirk Prawitt; Stefan Eder; Nicole Henninger; Khalifa El Malki; Nadine Lehmann; Nora Backes; Lea Roth; Larissa Seidmann; Clemens Sommer; Marc A Brockmann; Gundula Staatz; Heinz Schmidberger; Jörg Faber
Journal:  Oncotarget       Date:  2017-12-11

6.  Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies.

Authors:  Victor M Lu; Toni Rose Jue; Kerrie L McDonald
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.